New Ray Medicine International Holding Limited provided earnings guidance for the six months ended 30 June 2021. The board of directors of the Company informed the shareholders of the company and potential investors that, based on a preliminary review and analysis of the latest available unaudited consolidated management accounts of the Company, it is expected that the Group will record a net profit of approximately HKD 1.1 million for the six months ended 30 June 2021 as compared to the unaudited net loss of approximately HKD 36.4 million recorded by the Group for the six months ended 30 June 2020.